Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
artificial intelligence in cardiology

Tech companies team up to help cardiologists reach high-risk heart patients

Guidehealth and Story Health are joining forces to put AI-powered technology in the hands of heart teams. 

Thomas Maddox, MD, explains some of the new, innovative technologies people should watch for in cardiology. He said some of these may define how cardiologist practice medicine in the next couple years.

Remote monitoring, AI to play key roles in the future of cardiology

Serious changes could be coming to a cardiology practice near you.

AliveCor, a California-based healthcare company focused on developing on-the-go electrocardiography (ECG) devices, has gained U.S. Food and Drug Administration (FDA) clearance for its KAI 12L artificial intelligence (AI) technology and the new handheld Kardia 12L ECG System.

Dual approvals: AliveCor gains FDA clearance for advanced AI model, handheld ECG system

One of the company's new approvals was for a pocket-sized ECG system designed to be less invasive and easier to use than other devices on the market. 

How long do wearable cardiac monitors record data?

Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection of more data.

Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

Joel Sauer, MBA, MedAxoim, explains why there is a big business trend in cardiology toward remote monitoring and telehealth to cut costs. #ACC #MedAxiom #Telecardiology #remotemonitoring #ACC2024

Telemedicine, remote monitoring help reduce healthcare costs

As profit margins in healthcare continue to shrink, telemedicine and remote monitoring are seeing a large increase to help cut costs while still delivering care outside of the hospital.

Abbott has received U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) devices. While the Lingo system was developed for the general public, helping any adult track their glucose and make healthy lifestyle choices, the Libre Rio was designed specifically for adults with type 2 diabetes.

‘Different products for different people’: FDA clears 2 Abbott over-the-counter glucose monitors

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.

Jagmeet Singh, MD, PhD, Professor of Medicine, Harvard Medical School, and Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at Mass General Hospital, delivered a key note address at HRS 2024 on the future of artificial intelligence in EP and AI applications in cardiology. #HRS #EPeeps #HRS2024 #HRS24 #HealthAI

Embracing AI to enhance EP: Insights from cardiologist Jagmeet Singh

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

Displaying 17 - 24 of 106
Design by Adaptive Theme